Report: Diabetic Ketoacidosis Predictable Among Invokana Patients

A report published by the American Diabetes Association in its journal Diabetes Care discusses some key information for Invokana users and their doctors. In light of the FDA’s May 2015 concerns that Invokana may carry an increased risk of diabetic ketoacidosis (DKA), or high levels of acid in the blood, researchers from the Dallas Diabetes and Endocrine Center and the Institute of Clinical Physiology, Consiglio Nazionale delle Ricerche in Italy concluded that there are common factors among patients who take Invokana and subsequently experience DKA (including alcohol intake, intercurrent illness, reduced insulin levels, and stress), and that monitoring patients’ metabolic changes that occur right before a DKA event may help doctors identify patients who are at greater risk.

Lawsuits have been filed against Janssen and Johnson & Johnson, manufacturers of Invokana, alleging that the drugmakers failed to properly study Invokana’s effects and adequately warn patients of its dangerous risks, including DKA. If you or a loved one experienced complications such as kidney failure or ketoacidosis after taking Invokana, please call 888-973-6379. Experienced attorneys are standing by to help you navigate your potential claim and discuss any legal options you may have.

Real Time Analytics